secwatch.observer — SEC 8-K summary
======================================

Issuer:     ArriVent BioPharma, Inc. (AVBP)
CIK:        0001868279
Form:       8-K
Filed at:   2025-03-13T23:59:59+00:00
Accession:  0001558370-25-002912
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ArriVent BioPharma dismisses KPMG, appoints PwC as new auditor
--------------------------------------------------------------

- Audit Committee dismissed KPMG on March 11, 2025; no disagreements on accounting principles or audit scope.
- Previously reported material weaknesses in internal controls (manual journal entries, nonroutine transactions) were remediated as of Dec 31, 2024.
- PricewaterhouseCoopers LLP appointed as independent auditor for fiscal year 2025.
- No consultations with PwC prior to appointment regarding any contentious accounting matters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1868279/000155837025002912/0001558370-25-002912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1868279/000155837025002912/avbp-20250311x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-002912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer